TY  - GEN
AU  - Takeda,Y
AU  - Tsuduki,E
AU  - Izumi,S
AU  - Hojo,M
AU  - Kamimura,M
AU  - Naka,G
AU  - Kobayashi,K
AU  - Kudo,K
TI  - A phase I/II trial of irinotecan-cisplatin combined with an anti-late-diarrhoeal programme to evaluate the safety and antitumour response of this combination therapy in patients with advanced non-small-cell lung cancer
SN  - 0007-0920
PY  - 2006///0125
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antacids
KW  - administration & dosage
KW  - Antidiarrheals
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Area Under Curve
KW  - Camptothecin
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cholagogues and Choleretics
KW  - Cisplatin
KW  - Diarrhea
KW  - chemically induced
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Irinotecan
KW  - Lung Neoplasms
KW  - Magnesium Oxide
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Sodium Bicarbonate
KW  - Survival Analysis
KW  - Ursodeoxycholic Acid
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1038/sj.bjc.6602866
ER  -